We recently reported CRBN protein levels to be downregulated in iberdomide-resistant MM cells conferring cross-resistance to pomalidomide, whereas MYC and IKZF3 protein levels were upregulated.25 This evidence concerns the gene CRBN and Miyoshi myopathy.